Table 1 Paraclinical results
From: Concomitant familial hypocalciuric hypercalcemia and single parathyroid adenoma: a case report
Year | Reference value | 2008 | 2017 | 2018 | 2019 | 2019 | 2019 | 2019 | 2019 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Month (date) | Oct | June | Jan | Feb | Sept 16 | Sept 17 | Sept 27 | Dec | May | Feb | ||
DNA | CASR, MEN1 (VUS2) | Reevaluation | ||||||||||
Ionized Ca2+ (mmol/L) | 1.15–1.35 | 1.60 | 1.88 | 1.77 | 1.89 | 1.71 | 1.55 | 1.45 | 1.51 | 1.54 | 1.58 | 1.53 |
Phosphate (mmol/L) | 0.71–1.53 | 0.64 | 0.52 | 0.72 | 0.57 | 0.57 | 0.71 | 0.60 | ||||
PTH (pmol/L) | 1.2–8.3 | 7.2 | 12.7 | 22.2 | 18.5 | 6.0 | 3.8 | 7.8 | 6.2 | 6.3 | ||
Vitamin D (nmol/L) | 50–160 | 30 | 88 | 46 | 57 | 69 | 64 | 64 | 69 | 74 | ||
Hemoglobin (mmol/L) | 8.3–10.5 | 9.6 | 9.9 | 9.4 | 8.9 | 8.9 | 9.0 | 9.2 | ||||
Creatinine (µmol/L) | 60–105 | 87 | 86 | 91 | 88 | 80 | 83 | 85 | 85 | |||
ALP (U/L) | 35–105 | 99 | 94 | 92 | 85 | 90 | 88 | 76 | 77 | |||
CCCR | 0.006 | |||||||||||
Cinacalcet (mg) | 0 | 0 | 120 | 120 | 0 | 0 | 0 | 0 | 0 | |||
Parathyroid scintigraphy | No focus | Left lower | ||||||||||
DXA | Normal BMD | |||||||||||
Surgery (pathology) | Adenoma left lower |